An Australian stem cell and regenerative medicine company

October 02, 2017

Cynata profiled in a special feature on platform technologies in Drug Development & Delivery

Cynata’s unique Cymerus™ mesenchymal stem cell technology is profiled in a new article on platform technologies in the new issue of industry publication Drug Development & Delivery

Derisking & Transforming Drug Development

September 04, 2017

Cynata Presentation at the 2017 Rodman & Renshaw Investment Conference

Please view our presentation at the 19th Annual Rodman & Renshaw Global Investment Conference

July 21, 2017

CNBC Interview With Ross Macdonald

Ross Macdonald tells CNBC about how the company has progressed to a phase 1 clinical trial

Watch Interview

July 11, 2017

Q&A With Ross Macdonald

Q&A between Cynata CEO Dr Ross Macdonald and the respected and influential industry commentator Professor Paul Knoepfler of the UC Davis School of Medicine

Read More

June 01, 2017

A brief description of some of Cynata’s activities

A brief presentation on recent activities at Cynata